Fig. 8From: The impact of CBP expression in estrogen receptor-positive breast cancerCorrelation of CBP and GCN5 expression with breast cancer patientsā survival. a, b KaplanāMeier survival curves of disease-free survival for a CBP and b GCN5 expression. c, d Representative c overall survival and d disease-free survival curves for both CBP and GCN5 expression. e, f 5-year disease-free survival and overall survival analyses for e CREBBP and f KAT2A mRNA expression (http://kmplot.com/). g Overall survival curves for CREBBP and KAT2A amplification in breast cancer patients. Significant differences were calculated using the log-rank test. pā<ā0.05 is statistically significantBack to article page